Terms: = Uterine cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Clinical Outcome
6 results:
1. Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.
Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Carvalho L; Salgado L; Pereira D; Medeiros R
Sci Rep; 2023 Jun; 13(1):9519. PubMed ID: 37308506
[TBL] [Abstract] [Full Text] [Related]
2. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract] [Full Text] [Related]
3. Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.
Roque DM; Bellone S; English DP; Buza N; Cocco E; Gasparrini S; Bortolomai I; Ratner E; Silasi DA; Azodi M; Rutherford TJ; Schwartz PE; Santin AD
Cancer; 2013 Jul; 119(14):2582-92. PubMed ID: 23585021
[TBL] [Abstract] [Full Text] [Related]
4. A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study.
Benedetti Panici P; Greggi S; Amoroso M; Scambia G; Battaglia FA; Gebbia V; Salerno G; Paratore MP; Mancuso S
Int J Gynecol Cancer; 2001; 11(6):438-44. PubMed ID: 11906546
[TBL] [Abstract] [Full Text] [Related]
5. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
[TBL] [Abstract] [Full Text] [Related]
6. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
Bell SW; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
[TBL] [Abstract] [Full Text] [Related]